Skip to main content
Premium Trial:

Request an Annual Quote

Novartis to Close NIBR Genome & Proteome Sciences Group, Fold Activities into Other Programs

NEW YORK (GenomeWeb News) - Novartis is breaking up the Genome & Proteome Sciences program within the Cambridge, Mass.-based Novartis Institutes for Biomedical Research in order to restructure and “refocus” its programs and resources, a spokesman for the company confirmed today.
The company plans to continue ongoing projects that the department was pursuing, said Jeffrey Lockwood, NIBR’s director of external communications, but noted that most of the staff and programs will be absorbed by other units.
Lockwood said the decision to end the Genome & Proteome program – one of several so-called “expertise platforms” at NBIR -- came after “a regular review,” and said the move is not due to dissatisfaction with the content or cost of the program. 
“The commitment to that area will continue,” Lockwood said of proteomics, genomics, and informatics research. “It is just going to be integrated into another group.” 
Lockwood also confirmed that program head Mark Boguski, who joined NIBR in 2005, will be leaving the company to “pursue other opportunities” at the end of March.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.